iCarbonX
iCarbonX was founded in October 2015 by genomicist Jun Wang, the former CEO of BGI. Its first aim was AI-driven personal health management, built on genomic, proteomic, metabolomic and microbiome data. Since 2019 it has refocused on an open, one-stop multi-omics lab and data-analysis platform for biopharma and biotech partners. It is privately held and was valued at about $1B in 2018. Funding totals are reported as roughly $200M (Tencent, China Bridge Capital and others) up to $366M including a 2021 Series D. Headcount is small, at about 60–66 in 2026.
Funding
Every round, secondary, debt facility or acquisition involving iCarbonX that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in